Sector consensus Atossa Therapeutics, Inc.

Stocks

Delayed Nasdaq 14:02:48 2026-09-18 EDT			5-day change	1st Jan Change
2.320 ^USD	-3.33%		-7.57%	-73.79%

08-07	Atossa Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-28	Atossa Therapeutics Announces Publication of Novel (Z)-Endoxifen-Related Compounds Demonstrating Potent Anti-Cancer Activity in Er-Positive Breast Cancer	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Objective/dr gap	Nbr of analysts
ATOSSA THERAPEUTICS, INC.	18.67	+677.78%	3
LONZA GROUP AG	688.17	+26.27%	23
IQVIA HOLDINGS INC.	277.94	+3.16%	18
REVOLUTION MEDICINES, INC.	251.21	+27.56%	20
BEONE MEDICINES AG	432.8	+22.45%	28
CELLTRION, INC.	268,686.76	+49.02%	22
MEDPACE HOLDINGS, INC.	581.83	-5.42%	12
ASCENDIS PHARMA A/S	270.95	+30.8%	20
EUROFINS SCIENTIFIC SE	72.24	-6.03%	14
ICON PUBLIC LIMITED COMPANY	185.25	+9.18%	16
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	282.43	+0.27%	14
TEMPUS AI, INC.	68.18	-15.16%	17
BIO-TECHNE CORPORATION	70.73	-2.32%	11
PHARMARON BEIJING CO., LTD.	50.57	+15.59%	11
KYMERA THERAPEUTICS, INC.	137.73	+16.25%	22
PROTAGONIST THERAPEUTICS, INC.	174.69	+21.57%	13
ABIVAX	137.98	+47.25%	7
GENSCRIPT BIOTECH CORPORATION	3.908	-17.62%	7
QIAGEN N.V.	46.27	+4.25%	15
PRAXIS PRECISION MEDICINES, INC.	638.68	+105.72%	19
Average	13,653.85	+50.53%	16
Weighted average by Cap.	21,856.05	+18.33%	19